AKYA
Income statement / Annual
Last year (2024), Akoya Biosciences, Inc.'s total revenue was $81.67 M,
a decrease of 15.48% from the previous year.
In 2024, Akoya Biosciences, Inc.'s net income was -$55.37 M.
See Akoya Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$81.67 M |
$96.63 M |
$74.86 M |
$54.92 M |
$42.44 M |
$42.24 M |
| Cost of Revenue |
$33.79 M
|
$40.33 M
|
$31.47 M
|
$20.70 M
|
$16.54 M
|
$17.57 M
|
| Gross Profit |
$47.88 M
|
$56.31 M
|
$43.39 M
|
$34.22 M
|
$25.91 M
|
$24.66 M
|
| Gross Profit Ratio |
0.59
|
0.58
|
0.58
|
0.62
|
0.61
|
0.58
|
| Research and Development Expenses |
$19.75 M
|
$21.89 M
|
$23.21 M
|
$15.70 M
|
$9.60 M
|
$8.76 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$25.45 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$900,000.00
|
| Selling, General & Administrative Expenses |
$69.32 M
|
$82.38 M
|
$79.65 M
|
$51.02 M
|
$23.98 M
|
$26.35 M
|
| Other Expenses |
$5.55 M
|
$9.70 M
|
$6.73 M
|
$4.73 M
|
$3.82 M
|
$3.06 M
|
| Operating Expenses |
$94.61 M
|
$113.97 M
|
$109.60 M
|
$71.44 M
|
$37.40 M
|
$38.17 M
|
| Cost And Expenses |
$122.86 M
|
$154.30 M
|
$141.07 M
|
$92.14 M
|
$53.94 M
|
$55.74 M
|
| Interest Income |
$2.51 M
|
$3.49 M
|
$777,000.00
|
$91,000.00
|
$2.72 M
|
$1.88 M
|
| Interest Expense |
$10.43 M
|
$8.76 M
|
$4.55 M
|
$3.12 M
|
$2.72 M
|
$1.88 M
|
| Depreciation & Amortization |
$7.65 M
|
$8.89 M
|
$7.15 M
|
$4.79 M
|
$3.82 M
|
$3.06 M
|
| EBITDA |
-$37.14 M |
-$45.63 M |
-$58.82 M |
-$35.17 M |
-$10.13 M |
-$9.62 M |
| EBITDA Ratio |
-0.45
|
-0.47
|
-0.79
|
-0.64
|
-0.24
|
-0.23
|
| Operating Income Ratio |
-0.57
|
-0.6
|
-0.88
|
-0.68
|
-0.27
|
-0.32
|
| Total Other Income/Expenses Net |
-$8.49 M
|
-$5.62 M
|
-$4.41 M
|
-$3.78 M
|
-$4.65 M
|
-$2.25 M
|
| Income Before Tax |
-$55.22 M
|
-$63.28 M
|
-$70.52 M
|
-$43.08 M
|
-$16.66 M
|
-$14.56 M
|
| Income Before Tax Ratio |
-0.68
|
-0.65
|
-0.94
|
-0.78
|
-0.39
|
-0.34
|
| Income Tax Expense |
$146,000.00
|
$40,000.00
|
$123,000.00
|
-$140,000.00
|
$42,000.00
|
$194,000.00
|
| Net Income |
-$55.37 M
|
-$63.32 M
|
-$70.64 M
|
-$42.94 M
|
-$16.71 M
|
-$14.75 M
|
| Net Income Ratio |
-0.68
|
-0.66
|
-0.94
|
-0.78
|
-0.39
|
-0.35
|
| EPS |
-1.12 |
-1.43 |
-1.87 |
-1.15 |
-0.45 |
-0.4 |
| EPS Diluted |
-1.12 |
-1.43 |
-1.87 |
-1.15 |
-0.45 |
-0.4 |
| Weighted Average Shares Out |
$49.42 M
|
$44.43 M
|
$37.75 M
|
$37.42 M
|
$37.11 M
|
$37.11 M
|
| Weighted Average Shares Out Diluted |
$49.42 M
|
$44.43 M
|
$37.75 M
|
$37.42 M
|
$37.11 M
|
$37.11 M
|
| Link |
|
|
|
|
|
|
